IVERS-READ GILLIAN C

CIK 00012683042 companiesBOULDER, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001268304

Recent Transactions

32 trades

Exercise/Conversion
Clovis Oncology, Inc.
Restricted Stock Units
2020-06-03−625→ 1,875 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2020-06-03+687→ 208,122 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2020-06-03+625→ 207,720 total
Sale
Clovis Oncology, Inc.
Common Stock
2020-06-03$7.03/sh−313→ 207,809 total
Exercise/Conversion
Clovis Oncology, Inc.
Restricted Stock Units
2020-06-03−687→ 4,813 total
Sale
Clovis Oncology, Inc.
Common Stock
2020-06-03$7.03/sh−285→ 207,435 total
Sale
Clovis Oncology, Inc.
Common Stock
2017-09-15$69.50/sh−3,000→ 191,583 total
Sale
Clovis Oncology, Inc.
Common Stock
2017-09-15$69.50/sh−3,000→ 191,583 total
Sale
Clovis Oncology, Inc.
Common Stock
2017-04-17$56.02/sh−3,000→ 206,583 total
Sale
Clovis Oncology, Inc.
Common Stock
2017-04-17$56.02/sh−3,000→ 206,583 total
Other
Clovis Oncology, Inc.
Stock Option (right to buy)
2016-09-16−8,750→ 26,250 total
Other
Clovis Oncology, Inc.
Stock Option (right to buy)
2016-09-16−8,750→ 26,250 total
Conversion
Clovis Oncology, Inc.
Common Stock
2011-11-21+5,147→ 211,053 total
Conversion
Clovis Oncology, Inc.
Series A-2 Convertible Preferred Stock
2011-11-21−6,897→ 0 total
Conversion
Clovis Oncology, Inc.
Series B Convertible Preferred Stock
2011-11-21−14,928→ 0 total
Purchase
Clovis Oncology, Inc.
Common Stock
2011-11-21$13.00/sh+5,323→ 218,583 total
Conversion
Clovis Oncology, Inc.
Common Stock
2011-11-21+2,378→ 205,906 total
Conversion
Clovis Oncology, Inc.
Convertible Promissory Notes
2011-11-21→ 0 total
Conversion
Clovis Oncology, Inc.
Series A-1 Convertible Preferred Stock
2011-11-21−6,897→ 0 total
Conversion
Clovis Oncology, Inc.
Common Stock
2011-11-21+2,207→ 213,260 total
Conversion
Clovis Oncology, Inc.
Series A-2 Convertible Preferred Stock
2011-11-21−6,897→ 0 total
Conversion
Clovis Oncology, Inc.
Common Stock
2011-11-21+2,378→ 203,528 total
Purchase
Clovis Oncology, Inc.
Common Stock
2011-11-21$13.00/sh+5,323→ 218,583 total
Conversion
Clovis Oncology, Inc.
Series A-1 Convertible Preferred Stock
2011-11-21−6,897→ 0 total
Conversion
Clovis Oncology, Inc.
Common Stock
2011-11-21+5,147→ 211,053 total
Conversion
Clovis Oncology, Inc.
Convertible Promissory Notes
2011-11-21→ 0 total
Conversion
Clovis Oncology, Inc.
Series B Convertible Preferred Stock
2011-11-21−14,928→ 0 total
Conversion
Clovis Oncology, Inc.
Common Stock
2011-11-21+2,378→ 203,528 total
Conversion
Clovis Oncology, Inc.
Common Stock
2011-11-21+2,378→ 205,906 total
Conversion
Clovis Oncology, Inc.
Common Stock
2011-11-21+2,207→ 213,260 total
Award
PHARMION CORP
Employee Stock Option (right to buy)
2003-12-02+25,000→ 25,000 total
Award
PHARMION CORP
Employee Stock Option (right to buy)
2003-12-02+25,000→ 25,000 total

Companies

Recent Filings

Address

C/O CLOVIS ONCOLOGY, INC. 5500 FLATIRON PARKWAY, SUITE 100

BOULDER, CO, 80301

View on SEC.gov